Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil

This article examines the impact of treatment delay on the outcomes of patients with breast cancer, comparing results of those utilizing the public health systems in Harris County (Texas, USA) and Southeast Brazil.

[1]  W. King,et al.  Mortality due to cancer treatment delay: systematic review and meta-analysis , 2020, BMJ.

[2]  G. Hortobagyi,et al.  Impact of delayed neoadjuvant systemic chemotherapy on overall survival among breast cancer patients. , 2020, The oncologist.

[3]  Ahmedin Jemal,et al.  Breast cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[4]  H. Salehiniya,et al.  Epidemiological characteristics of and risk factors for breast cancer in the world , 2019, Breast cancer.

[5]  C. Barrios,et al.  Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study. , 2019, Breast.

[6]  A. Khorana,et al.  Time to initial cancer treatment in the United States and association with survival over time: An observational study , 2019, PloS one.

[7]  S. Siddharth,et al.  Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants , 2018, Cancers.

[8]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[9]  Y. Kuo,et al.  Trends in breast cancer mortality by stage at diagnosis among young women in the United States , 2018, Cancer.

[10]  R. Atun,et al.  The Brazilian health system at crossroads: progress, crisis and resilience , 2018, BMJ Global Health.

[11]  D. Constant,et al.  From symptom discovery to treatment - women's pathways to breast cancer care: a cross-sectional study , 2018, BMC Cancer.

[12]  Melissa Matz,et al.  Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.

[13]  Karriem S. Watson,et al.  Disparity in breast cancer mortality by age and geography in 10 racially diverse US cities , 2018, Cancer epidemiology.

[14]  K. Mcgregor,et al.  Global cancer control: responding to the growing burden, rising costs and inequalities in access , 2018, ESMO Open.

[15]  Oguzhan Alagoz,et al.  Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012 , 2018, JAMA.

[16]  F. Fu,et al.  Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis , 2017, Oncotarget.

[17]  R. Bleicher,et al.  Timing and Delays in Breast Cancer Evaluation and Treatment , 2018, Annals of Surgical Oncology.

[18]  Kimberly J. Johnson,et al.  Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old , 2017, Cancer.

[19]  A. P. Benveniste,et al.  Quality Improvement of Breast Imaging Workup and Core-Needle Biopsy Program in a County Health Care Program. , 2017, Journal of the American College of Radiology : JACR.

[20]  S. Giordano,et al.  Impact of delayed neoadjuvant systemic chemotherapy on survival outcomes in breast cancer patients. , 2016 .

[21]  J. Beck,et al.  Time to Surgery and Breast Cancer Survival in the United States. , 2016, JAMA oncology.

[22]  S. Giordano,et al.  Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer. , 2016, JAMA oncology.

[23]  M. Weller,et al.  Patient delays and system delays in breast cancer treatment in developed and developing countries. , 2015, Ciencia & saude coletiva.

[24]  G. Uemura,et al.  Evaluating Breast Cancer Health System Between Countries: The Use of USA/SEER and Brazilian Women as a Cohort Sample , 2015, The breast journal.

[25]  K. Unger-Saldaña,et al.  Health system delay and its effect on clinical stage of breast cancer: Multicenter study , 2015, Cancer.

[26]  Oguzhan Alagoz,et al.  Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. , 2014, Journal of the National Cancer Institute.

[27]  J. Jassem,et al.  Delays in diagnosis and treatment of breast cancer: a multinational analysis. , 2014, European journal of public health.

[28]  S. Dey,et al.  Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal. , 2014, World journal of clinical oncology.

[29]  L. Caplan,et al.  Delay in Breast Cancer: Implications for Stage at Diagnosis and Survival , 2014, Front. Public Health.

[30]  R. Freitas-Junior,et al.  Disparities in female breast cancer mortality rates between urban centers and rural areas of Brazil: ecological time-series study. , 2014, Breast.

[31]  H. Gobbi,et al.  Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital - a closer look into cause-specific mortality , 2013, BMC Cancer.

[32]  L. Highfield.  Spatial Patterns of Breast Cancer Incidence and Uninsured Women of Mammography Screening Age , 2013, The breast journal.

[33]  Y. Collan,et al.  Diagnosis delay in Libyan female breast cancer , 2012, BMC Research Notes.

[34]  R. Freitas-Junior,et al.  Disparities in female breast cancer mortality rates in Brazil between 1980 and 2009 , 2012, Clinics.

[35]  Alan D. Lopez,et al.  Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis , 2011, The Lancet.

[36]  J. Weissfeld,et al.  The effect of delays in treatment for breast cancer metastasis on survival , 2011, Breast Cancer Research and Treatment.

[37]  Jeffrey D Sachs,et al.  Expansion of cancer care and control in countries of low and middle income: a call to action , 2010, The Lancet.

[38]  Pierre Goovaerts,et al.  MethodologyIdentification of racial disparities in breast cancer mortality : does scale matter ? , 2015 .

[39]  O. Brawley,et al.  Religiosity, Spirituality, and Cancer Fatalism Beliefs on Delay in Breast Cancer Diagnosis in African American Women , 2010, Journal of Religion and Health.

[40]  M. Redondo,et al.  Prognostic implications of emergency admission and delays in patients with breast cancer , 2009, Supportive Care in Cancer.

[41]  M. Bottai,et al.  Breast Cancer Survival among Economically Disadvantaged Women: The Influences of Delayed Diagnosis and Treatment on Mortality , 2008, Cancer Epidemiology Biomarkers & Prevention.

[42]  A. D. Giglio,et al.  Análise do atraso no diagnóstico e tratamento do câncer de mama em um hospital público. , 2008 .

[43]  M. Ugá,et al.  An analysis of equity in Brazilian health system financing. , 2007, Health affairs.

[44]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[45]  Dino Amadori,et al.  The global breast cancer burden: variations in epidemiology and survival. , 2005, Clinical breast cancer.

[46]  A. Neugut,et al.  Racial disparities in treatment and survival among women with early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  L. Goldstein,et al.  Prognostic and predictive factors in early-stage breast cancer. , 2004, The oncologist.

[48]  F. Bray,et al.  The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.

[49]  A. Ellis.  Breast , 2002, BMJ : British Medical Journal.

[50]  Hermann Brenner,et al.  Provider delay among patients with breast cancer in Germany: a population-based study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  A. Recht,et al.  Race, socioeconomic status, and breast carcinoma in the U.S. , 2002, Cancer.

[52]  G Dhom,et al.  Patient delay and stage of diagnosis among breast cancer patients in Germany – a population based study , 2002, British Journal of Cancer.

[53]  B. Haward,et al.  Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis , 1999, The Lancet.

[54]  Philip Smith,et al.  The influence on survival of delay in the presentation and treatment of symptomatic breast cancer , 1999, British Journal of Cancer.

[55]  S. Love,et al.  Who and what influences delayed presentation in breast cancer? , 1998, British Journal of Cancer.

[56]  J. G. McGuire.  What in the world? , 1996, The Journal of school health.

[57]  H. Sommer,et al.  Patient's and doctor's delay in primary breast cancer. Prognostic implications. , 1994, Acta oncologica.